Scholarlink

Building on a prior discussion of medicinal chemistry and the role of small molecules, this chapter focuses on praziquantel. Its chemical classification as a tetrahydroisoquinoline is detailed, alongside an analysis of key molecular descriptors and physicochemical properties. Additionally, the industrial-scale synthesis of praziquantel and its characterization are examined in the context of its development as a drug product. These insights provide a comprehensive overview of praziquantel’s attributes and its relevance in medicinal chemistry.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

From Small Molecule to Drug Product: The Chemical Journey of Praziquantel

  • 章节

  • 出版模式：

    开放获取

  • 发表日期：

    2026年

查看全文
  • David Maillard,
  • Thomas Spangenberg,
  • Yara Sylla

摘要

Building on a prior discussion of medicinal chemistry and the role of small molecules, this chapter focuses on praziquantel. Its chemical classification as a tetrahydroisoquinoline is detailed, alongside an analysis of key molecular descriptors and physicochemical properties. Additionally, the industrial-scale synthesis of praziquantel and its characterization are examined in the context of its development as a drug product. These insights provide a comprehensive overview of praziquantel’s attributes and its relevance in medicinal chemistry.